| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ABCC1 ABCA1 ABCA3 SLCO4A1 SLC24A3 SLC34A3 SLC10A7 ABCA7 SLC5A3 SLC6A9 SLC8A2 SLC16A5 SLC45A3 SLC22A1 SLC37A4 ABCC10 | 2.92e-09 | 477 | 103 | 16 | GO:0022804 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | ABCC1 ABCA1 ABCA3 SLCO4A1 SLC24A3 SLC34A3 SLC10A7 ABCA7 SLC2A3 CEACAM1 SLC5A3 SLC6A9 SLC8A2 CACNA2D4 SLC16A5 SLC45A3 SLC22A1 TRPV2 KCNMB1 SLC37A4 ABCC10 MFSD3 | 1.18e-07 | 1180 | 103 | 22 | GO:0022857 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLCO4A1 SLC24A3 SLC34A3 SLC10A7 SLC5A3 SLC6A9 SLC8A2 SLC16A5 SLC45A3 SLC22A1 SLC37A4 | 3.76e-07 | 296 | 103 | 11 | GO:0015291 |
| GeneOntologyMolecularFunction | transporter activity | ABCC1 ABCA1 ABCA3 SLCO4A1 SLC24A3 SLC34A3 SLC10A7 ABCA7 SLC2A3 CEACAM1 SLC5A3 SLC6A9 SLC8A2 CACNA2D4 SLC16A5 SLC45A3 SLC22A1 TRPV2 KCNMB1 SLC37A4 ABCC10 MFSD3 | 5.37e-07 | 1289 | 103 | 22 | GO:0005215 |
| GeneOntologyMolecularFunction | symporter activity | SLC24A3 SLC34A3 SLC10A7 SLC5A3 SLC6A9 SLC16A5 SLC45A3 SLC22A1 | 1.09e-06 | 150 | 103 | 8 | GO:0015293 |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 5.27e-06 | 49 | 103 | 5 | GO:0140359 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 8.01e-06 | 196 | 103 | 8 | GO:0005319 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | HJV PRLHR ABCA1 GPR65 TAS1R3 GPR152 SSTR4 ABCA7 IFNLR1 ADORA1 OR52R1 TAS2R5 CSF3R NRXN1 GPR150 PTCH2 C5AR1 OR56A1 OR56B4 ALK | 1.66e-05 | 1353 | 103 | 20 | GO:0004888 |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | ABCC1 SLCO4A1 SLC10A7 SLC2A3 CEACAM1 SLC6A9 SLC16A5 SLC22A1 SLC37A4 | 2.10e-05 | 293 | 103 | 9 | GO:0008514 |
| GeneOntologyMolecularFunction | apolipoprotein A-I receptor activity | 2.64e-05 | 2 | 103 | 2 | GO:0034188 | |
| GeneOntologyMolecularFunction | xenobiotic transmembrane transporter activity | 2.75e-05 | 34 | 103 | 4 | GO:0042910 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 3.77e-05 | 73 | 103 | 5 | GO:0170055 | |
| GeneOntologyMolecularFunction | ABC-type xenobiotic transporter activity | 5.80e-05 | 15 | 103 | 3 | GO:0008559 | |
| GeneOntologyMolecularFunction | apolipoprotein receptor activity | 7.88e-05 | 3 | 103 | 2 | GO:0030226 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | ABCC1 SLC24A3 SLC34A3 SLC5A3 SLC6A9 SLC8A2 CACNA2D4 SLC45A3 SLC22A1 TRPV2 KCNMB1 SLC37A4 ABCC10 | 1.41e-04 | 758 | 103 | 13 | GO:0015318 |
| GeneOntologyMolecularFunction | phosphatidylcholine transporter activity | 1.43e-04 | 20 | 103 | 3 | GO:0008525 | |
| GeneOntologyMolecularFunction | ion channel regulator activity | 1.94e-04 | 162 | 103 | 6 | GO:0099106 | |
| GeneOntologyMolecularFunction | potassium channel regulator activity | 2.14e-04 | 57 | 103 | 4 | GO:0015459 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 2.53e-04 | 109 | 103 | 5 | GO:0042626 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 2.60e-04 | 171 | 103 | 6 | GO:0015081 | |
| GeneOntologyMolecularFunction | channel regulator activity | 2.86e-04 | 174 | 103 | 6 | GO:0016247 | |
| GeneOntologyMolecularFunction | transporter regulator activity | 3.13e-04 | 177 | 103 | 6 | GO:0141108 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 3.80e-04 | 119 | 103 | 5 | GO:0015294 | |
| GeneOntologyMolecularFunction | retinoic acid binding | 3.98e-04 | 28 | 103 | 3 | GO:0001972 | |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 3.98e-04 | 28 | 103 | 3 | GO:0140326 | |
| GeneOntologyMolecularFunction | sugar transmembrane transporter activity | 4.42e-04 | 29 | 103 | 3 | GO:0051119 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 4.71e-04 | 70 | 103 | 4 | GO:1901618 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | SLC24A3 SLC34A3 SLC5A3 SLC6A9 SLC8A2 CACNA2D4 SLC22A1 TRPV2 KCNMB1 | 6.76e-04 | 465 | 103 | 9 | GO:0046873 |
| GeneOntologyMolecularFunction | ABC-type glutathione S-conjugate transporter activity | 7.23e-04 | 8 | 103 | 2 | GO:0015431 | |
| GeneOntologyMolecularFunction | phosphatidylcholine floppase activity | 7.23e-04 | 8 | 103 | 2 | GO:0090554 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 8.19e-04 | 81 | 103 | 4 | GO:0015370 | |
| GeneOntologyMolecularFunction | vitamin transmembrane transporter activity | 8.41e-04 | 36 | 103 | 3 | GO:0090482 | |
| GeneOntologyMolecularFunction | phosphatidylserine floppase activity | 9.26e-04 | 9 | 103 | 2 | GO:0090556 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 9.51e-04 | 301 | 103 | 7 | GO:0022853 | |
| GeneOntologyMolecularFunction | calcium:sodium antiporter activity | 1.15e-03 | 10 | 103 | 2 | GO:0005432 | |
| GeneOntologyMolecularFunction | ATPase-coupled inorganic anion transmembrane transporter activity | 1.15e-03 | 10 | 103 | 2 | GO:0043225 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 1.21e-03 | 90 | 103 | 4 | GO:0008028 | |
| GeneOntologyMolecularFunction | carbohydrate transmembrane transporter activity | 1.32e-03 | 42 | 103 | 3 | GO:0015144 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | SLC24A3 SLC34A3 SLC5A3 SLC6A9 SLC8A2 CACNA2D4 SLC45A3 SLC22A1 TRPV2 KCNMB1 | 1.49e-03 | 627 | 103 | 10 | GO:0022890 |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 1.93e-03 | 171 | 103 | 5 | GO:0015103 | |
| GeneOntologyMolecularFunction | retinoid binding | 1.95e-03 | 48 | 103 | 3 | GO:0005501 | |
| GeneOntologyMolecularFunction | calcium:monoatomic cation antiporter activity | 1.98e-03 | 13 | 103 | 2 | GO:0015368 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | PRLHR GPR65 TAS1R3 GPR152 SSTR4 ADORA1 OR52R1 TAS2R5 GPR150 C5AR1 OR56A1 OR56B4 | 1.99e-03 | 884 | 103 | 12 | GO:0004930 |
| GeneOntologyMolecularFunction | isoprenoid binding | 2.07e-03 | 49 | 103 | 3 | GO:0019840 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | SLC24A3 SLC34A3 SLC5A3 SLC6A9 SLC8A2 CACNA2D4 SLC45A3 SLC22A1 TRPV2 KCNMB1 | 2.27e-03 | 664 | 103 | 10 | GO:0008324 |
| GeneOntologyMolecularFunction | prostaglandin transmembrane transporter activity | 2.30e-03 | 14 | 103 | 2 | GO:0015132 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 2.30e-03 | 178 | 103 | 5 | GO:0015399 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 2.32e-03 | 51 | 103 | 3 | GO:0140303 | |
| GeneOntologyMolecularFunction | icosanoid transmembrane transporter activity | 2.65e-03 | 15 | 103 | 2 | GO:0071714 | |
| GeneOntologyMolecularFunction | acetylcholine receptor binding | 3.02e-03 | 16 | 103 | 2 | GO:0033130 | |
| GeneOntologyMolecularFunction | floppase activity | 3.02e-03 | 16 | 103 | 2 | GO:0140328 | |
| GeneOntologyMolecularFunction | carbohydrate:monoatomic cation symporter activity | 3.41e-03 | 17 | 103 | 2 | GO:0005402 | |
| GeneOntologyMolecularFunction | sulfur compound transmembrane transporter activity | 3.86e-03 | 61 | 103 | 3 | GO:1901682 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 4.39e-03 | 207 | 103 | 5 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 4.48e-03 | 208 | 103 | 5 | GO:0005342 | |
| GeneOntologyMolecularFunction | sphingolipid transporter activity | 4.71e-03 | 20 | 103 | 2 | GO:0046624 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 4.76e-03 | 211 | 103 | 5 | GO:0016758 | |
| GeneOntologyMolecularFunction | BMP binding | 5.69e-03 | 22 | 103 | 2 | GO:0036122 | |
| GeneOntologyMolecularFunction | glucosyltransferase activity | 5.69e-03 | 22 | 103 | 2 | GO:0046527 | |
| GeneOntologyMolecularFunction | phospholipid transporter activity | 6.63e-03 | 74 | 103 | 3 | GO:0005548 | |
| GeneOntologyBiologicalProcess | vascular process in circulatory system | ABCC1 PDE3A SLC24A3 ITGA1 SLC2A3 CEACAM1 SLC5A3 ADORA1 SLC6A9 SLC8A2 SLC22A1 KCNMB1 | 2.81e-07 | 344 | 109 | 12 | GO:0003018 |
| GeneOntologyBiologicalProcess | transport across blood-brain barrier | 3.91e-07 | 87 | 109 | 7 | GO:0150104 | |
| GeneOntologyBiologicalProcess | vascular transport | 4.23e-07 | 88 | 109 | 7 | GO:0010232 | |
| GeneOntologyBiologicalProcess | phospholipid efflux | 9.63e-07 | 15 | 109 | 4 | GO:0033700 | |
| GeneOntologyBiologicalProcess | organic anion transport | ABCC1 SLCO4A1 SSTR4 SLC10A7 SLC2A3 CEACAM1 ADORA1 SLC6A9 SLC16A5 SLC22A1 UMOD SLC37A4 ABCC10 | 3.32e-06 | 515 | 109 | 13 | GO:0015711 |
| GeneOntologyBiologicalProcess | circulatory system process | ABCC1 PDE3A SLC24A3 ITGA1 CAV3 SLC2A3 CEACAM1 SLC5A3 ADORA1 SLC6A9 SLC8A2 PRCP SLC22A1 KCNMB1 UMOD | 7.21e-06 | 733 | 109 | 15 | GO:0003013 |
| GeneOntologyBiologicalProcess | carboxylic acid transport | ABCC1 SLCO4A1 SSTR4 SLC10A7 CEACAM1 ADORA1 SLC6A9 SLC16A5 SLC22A1 UMOD ABCC10 | 1.12e-05 | 410 | 109 | 11 | GO:0046942 |
| GeneOntologyBiologicalProcess | organic acid transport | ABCC1 SLCO4A1 SSTR4 SLC10A7 CEACAM1 ADORA1 SLC6A9 SLC16A5 SLC22A1 UMOD ABCC10 | 1.17e-05 | 412 | 109 | 11 | GO:0015849 |
| GeneOntologyBiologicalProcess | icosanoid transport | 4.24e-05 | 73 | 109 | 5 | GO:0071715 | |
| GeneOntologyBiologicalProcess | tetrapyrrole catabolic process | 5.01e-05 | 14 | 109 | 3 | GO:0033015 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 1.07e-04 | 275 | 109 | 8 | GO:0006814 | |
| GeneOntologyBiologicalProcess | regulation of NMDA receptor activity | 1.11e-04 | 18 | 109 | 3 | GO:2000310 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid transport | 1.39e-04 | 213 | 109 | 7 | GO:0015718 | |
| GeneOntologyBiologicalProcess | regulation of phospholipid efflux | 1.65e-04 | 4 | 109 | 2 | GO:1902994 | |
| GeneOntologyBiologicalProcess | positive regulation of phospholipid efflux | 1.65e-04 | 4 | 109 | 2 | GO:1902995 | |
| GeneOntologyBiologicalProcess | regulation of neurotransmitter receptor activity | 2.19e-04 | 56 | 109 | 4 | GO:0099601 | |
| GeneOntologyBiologicalProcess | vitamin transport | 2.19e-04 | 56 | 109 | 4 | GO:0051180 | |
| GeneOntologyBiologicalProcess | sphingolipid translocation | 2.74e-04 | 5 | 109 | 2 | GO:0099039 | |
| GeneOntologyBiologicalProcess | lipid translocation | 2.87e-04 | 60 | 109 | 4 | GO:0034204 | |
| GeneOntologyBiologicalProcess | immunoglobulin production | IGKV3D-20 IGKV3D-15 IGKV3D-11 IGKV1D-42 IGKV3-20 IGKV3-15 IGKV3-7 | 2.95e-04 | 241 | 109 | 7 | GO:0002377 |
| GeneOntologyBiologicalProcess | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules | 3.46e-04 | 63 | 109 | 4 | GO:0007157 | |
| GeneOntologyBiologicalProcess | lipid transport | ABCC1 ABCA1 ABCA3 SLCO4A1 SSTR4 SLC10A7 ABCA7 CEACAM1 SLC22A1 ABCC10 | 3.52e-04 | 506 | 109 | 10 | GO:0006869 |
| GeneOntologyBiologicalProcess | xenobiotic transport | 3.67e-04 | 64 | 109 | 4 | GO:0042908 | |
| GeneOntologyBiologicalProcess | positive regulation of cholesterol efflux | 3.83e-04 | 27 | 109 | 3 | GO:0010875 | |
| GeneOntologyBiologicalProcess | regulation of membrane lipid distribution | 3.90e-04 | 65 | 109 | 4 | GO:0097035 | |
| GeneOntologyBiologicalProcess | xenobiotic transport across blood-brain barrier | 4.09e-04 | 6 | 109 | 2 | GO:1990962 | |
| GeneOntologyBiologicalProcess | inorganic ion homeostasis | HJV SLC24A3 SLC34A3 CAV3 GDF2 SLC10A7 ADORA1 SLC8A2 TMEM203 UMOD SLC37A4 | 4.55e-04 | 622 | 109 | 11 | GO:0098771 |
| GeneOntologyBiologicalProcess | leukotriene transport | 5.71e-04 | 7 | 109 | 2 | GO:0071716 | |
| GeneOntologyBiologicalProcess | apolipoprotein A-I-mediated signaling pathway | 5.71e-04 | 7 | 109 | 2 | GO:0038027 | |
| GeneOntologyBiologicalProcess | tetrapyrrole metabolic process | 6.07e-04 | 73 | 109 | 4 | GO:0033013 | |
| GeneOntologyBiologicalProcess | neutrophil migration | 6.37e-04 | 130 | 109 | 5 | GO:1990266 | |
| GeneOntologyBiologicalProcess | intracellular calcium ion homeostasis | 6.43e-04 | 359 | 109 | 8 | GO:0006874 | |
| GeneOntologyBiologicalProcess | regulation of signaling receptor activity | 6.60e-04 | 131 | 109 | 5 | GO:0010469 | |
| GeneOntologyBiologicalProcess | glomerular filtration | 6.98e-04 | 33 | 109 | 3 | GO:0003094 | |
| GeneOntologyCellularComponent | basal part of cell | HJV ABCC1 ABCA1 SLCO4A1 ITGA1 CEACAM1 SLC5A3 ADORA1 SLC6A9 SLC8A2 SLC16A5 PRCP SLC22A1 UMOD C5AR1 ABCC10 | 1.63e-10 | 378 | 111 | 16 | GO:0045178 |
| GeneOntologyCellularComponent | IgM immunoglobulin complex, circulating | 2.13e-10 | 8 | 111 | 5 | GO:0071754 | |
| GeneOntologyCellularComponent | pentameric IgM immunoglobulin complex | 2.13e-10 | 8 | 111 | 5 | GO:0071756 | |
| GeneOntologyCellularComponent | monomeric IgA immunoglobulin complex | 4.78e-10 | 9 | 111 | 5 | GO:0071748 | |
| GeneOntologyCellularComponent | polymeric IgA immunoglobulin complex | 9.51e-10 | 10 | 111 | 5 | GO:0071749 | |
| GeneOntologyCellularComponent | IgA immunoglobulin complex, circulating | 9.51e-10 | 10 | 111 | 5 | GO:0071746 | |
| GeneOntologyCellularComponent | secretory IgA immunoglobulin complex | 9.51e-10 | 10 | 111 | 5 | GO:0071751 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | HJV ABCC1 ABCA1 SLCO4A1 CEACAM1 SLC5A3 ADORA1 SLC6A9 SLC8A2 SLC16A5 SLC22A1 UMOD C5AR1 ABCC10 | 1.62e-09 | 320 | 111 | 14 | GO:0016323 |
| GeneOntologyCellularComponent | basal plasma membrane | HJV ABCC1 ABCA1 SLCO4A1 CEACAM1 SLC5A3 ADORA1 SLC6A9 SLC8A2 SLC16A5 SLC22A1 UMOD C5AR1 ABCC10 | 5.89e-09 | 354 | 111 | 14 | GO:0009925 |
| GeneOntologyCellularComponent | IgA immunoglobulin complex | 1.11e-08 | 15 | 111 | 5 | GO:0071745 | |
| GeneOntologyCellularComponent | IgM immunoglobulin complex | 1.11e-08 | 15 | 111 | 5 | GO:0071753 | |
| GeneOntologyCellularComponent | immunoglobulin complex, circulating | 2.27e-08 | 17 | 111 | 5 | GO:0042571 | |
| GeneOntologyCellularComponent | immunoglobulin complex | IGKV3D-20 IGKV3D-15 IGKV3D-11 IGKV1D-42 IGKV3-20 IGKV3-15 IGKV3-7 | 2.98e-05 | 166 | 111 | 7 | GO:0019814 |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | ABCA1 PGAP3 TMEM238L RASGRF2 CISD2 RPN2 UGT1A5 CYP26A1 GPAT3 TMEM214 ERN2 SLC10A7 UGT1A4 TMEM203 RNF103 RAB3GAP2 ALG8 SLC37A4 | 1.53e-04 | 1293 | 111 | 18 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | ABCA1 PGAP3 TMEM238L RASGRF2 CISD2 RPN2 UGT1A5 CYP26A1 GPAT3 TMEM214 ERN2 SLC10A7 UGT1A4 TMEM203 RNF103 RAB3GAP2 ALG8 SLC37A4 | 1.62e-04 | 1299 | 111 | 18 | GO:0098827 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | ABCA1 PGAP3 TMEM238L RASGRF2 CISD2 RPN2 UGT1A5 CYP26A1 GPAT3 TMEM214 ERN2 SLC10A7 UGT1A4 TMEM203 RNF103 RAB3GAP2 ALG8 SLC37A4 | 2.11e-04 | 1327 | 111 | 18 | GO:0042175 |
| GeneOntologyCellularComponent | cell surface | HJV ABCA1 SEMA7A ITGA1 CPM CAV3 CUBN ABCA7 CEACAM1 CSF3R NRXN1 TRPV2 UMOD C5AR1 STRC STRCP1 | 2.54e-04 | 1111 | 111 | 16 | GO:0009986 |
| GeneOntologyCellularComponent | apical plasma membrane | ABCC1 SLC34A3 CUBN ABCA7 CEACAM1 SLC5A3 SLC6A9 SLC22A1 ASPM UMOD | 2.71e-04 | 487 | 111 | 10 | GO:0016324 |
| GeneOntologyCellularComponent | apical part of cell | ABCC1 SLC34A3 CUBN ABCA7 CEACAM1 SLC5A3 SLC6A9 SLC22A1 ASPM UMOD C5AR1 | 3.14e-04 | 592 | 111 | 11 | GO:0045177 |
| GeneOntologyCellularComponent | lateral plasma membrane | 1.35e-03 | 90 | 111 | 4 | GO:0016328 | |
| GeneOntologyCellularComponent | side of membrane | HJV ABCA1 SEMA7A ITGA1 CPM CUBN CEACAM1 CSF3R DPEP2 UMOD ALG8 LYNX1 | 2.37e-03 | 875 | 111 | 12 | GO:0098552 |
| GeneOntologyCellularComponent | 9+2 non-motile cilium | 2.44e-03 | 14 | 111 | 2 | GO:0097732 | |
| GeneOntologyCellularComponent | kinocilium | 2.44e-03 | 14 | 111 | 2 | GO:0060091 | |
| Domain | ABC_transporter_CS | 3.19e-06 | 42 | 102 | 5 | IPR017871 | |
| Domain | ABC_tran | 6.25e-06 | 48 | 102 | 5 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 6.25e-06 | 48 | 102 | 5 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 6.93e-06 | 49 | 102 | 5 | PS00211 | |
| Domain | ABC_transporter-like | 7.67e-06 | 50 | 102 | 5 | IPR003439 | |
| Domain | MFS_dom | 8.76e-06 | 134 | 102 | 7 | IPR020846 | |
| Domain | MFS | 2.79e-05 | 108 | 102 | 6 | PS50850 | |
| Domain | TMEM191C | 2.95e-05 | 2 | 102 | 2 | PF15194 | |
| Domain | TMEM191B/C | 2.95e-05 | 2 | 102 | 2 | IPR028186 | |
| Domain | Transform_prot_C-ets | 2.95e-05 | 2 | 102 | 2 | IPR016311 | |
| Domain | ABC_A | 3.36e-05 | 12 | 102 | 3 | IPR026082 | |
| Domain | MFS_1 | 8.36e-04 | 77 | 102 | 4 | PF07690 | |
| Domain | MFS | 8.36e-04 | 77 | 102 | 4 | IPR011701 | |
| Domain | NaCa_Exmemb | 1.04e-03 | 9 | 102 | 2 | IPR004837 | |
| Domain | Na_Ca_ex | 1.04e-03 | 9 | 102 | 2 | PF01699 | |
| Domain | AAA+_ATPase | 1.16e-03 | 144 | 102 | 5 | IPR003593 | |
| Domain | AAA | 1.16e-03 | 144 | 102 | 5 | SM00382 | |
| Domain | PNT | 1.57e-03 | 11 | 102 | 2 | PS51433 | |
| Domain | Pointed_dom | 1.57e-03 | 11 | 102 | 2 | IPR003118 | |
| Domain | SAM_PNT | 1.57e-03 | 11 | 102 | 2 | PF02198 | |
| Domain | SAM_PNT | 1.57e-03 | 11 | 102 | 2 | SM00251 | |
| Domain | EGF_3 | 1.88e-03 | 12 | 102 | 2 | PF12947 | |
| Domain | EGF_dom | 1.88e-03 | 12 | 102 | 2 | IPR024731 | |
| Domain | 7TM_GPCR_Srsx | 3.32e-03 | 112 | 102 | 4 | SM01381 | |
| Domain | GPCR_Rhodpsn_7TM | PRLHR GPR65 GPR152 SSTR4 ADORA1 OR52R1 GPR150 C5AR1 OR56A1 OR56B4 | 3.62e-03 | 670 | 102 | 10 | IPR017452 |
| Domain | 7tm_1 | PRLHR GPR65 GPR152 SSTR4 ADORA1 OR52R1 GPR150 C5AR1 OR56A1 OR56B4 | 3.90e-03 | 677 | 102 | 10 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | PRLHR GPR65 GPR152 SSTR4 ADORA1 OR52R1 GPR150 C5AR1 OR56A1 OR56B4 | 4.23e-03 | 685 | 102 | 10 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | PRLHR GPR65 GPR152 SSTR4 ADORA1 OR52R1 GPR150 C5AR1 OR56A1 OR56B4 | 4.50e-03 | 691 | 102 | 10 | PS50262 |
| Domain | GPCR_Rhodpsn | PRLHR GPR65 GPR152 SSTR4 ADORA1 OR52R1 GPR150 C5AR1 OR56A1 OR56B4 | 4.54e-03 | 692 | 102 | 10 | IPR000276 |
| Domain | UDPGT | 5.80e-03 | 21 | 102 | 2 | PF00201 | |
| Domain | UDPGT | 5.80e-03 | 21 | 102 | 2 | PS00375 | |
| Domain | UDP_glucos_trans | 5.80e-03 | 21 | 102 | 2 | IPR002213 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ABCC1 ABCA1 ABCA3 SLCO4A1 SLC24A3 SLC34A3 CUBN ABCA7 SLC2A3 SLC5A3 SLC6A9 SLC8A2 SLC45A3 SLC22A1 TRPV2 ABCC10 | 3.60e-06 | 736 | 81 | 16 | M27287 |
| Pathway | KEGG_ABC_TRANSPORTERS | 5.04e-06 | 44 | 81 | 5 | M11911 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ABCC1 ABCA1 ABCA3 SLCO4A1 SLC24A3 SLC34A3 ABCA7 SLC2A3 SLC5A3 SLC6A9 SLC8A2 SLC45A3 SLC22A1 TRPV2 ABCC10 | 6.50e-06 | 681 | 81 | 15 | MM14985 |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLCO4A1 SLC24A3 SLC34A3 SLC2A3 SLC5A3 SLC6A9 SLC8A2 SLC45A3 SLC22A1 | 8.69e-06 | 238 | 81 | 9 | MM15076 |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLCO4A1 SLC24A3 SLC34A3 SLC2A3 SLC5A3 SLC6A9 SLC8A2 SLC45A3 SLC22A1 | 1.25e-05 | 249 | 81 | 9 | M5988 |
| Pathway | REACTOME_HEME_DEGRADATION | 1.94e-04 | 20 | 81 | 3 | MM14721 | |
| Pathway | REACTOME_CD22_MEDIATED_BCR_REGULATION | 4.12e-04 | 61 | 81 | 4 | M27581 | |
| Pathway | REACTOME_COMPLEMENT_CASCADE | 5.18e-04 | 115 | 81 | 5 | M19752 | |
| Pathway | REACTOME_FCGR_ACTIVATION | 6.59e-04 | 69 | 81 | 4 | M27108 | |
| Pathway | REACTOME_SCAVENGING_OF_HEME_FROM_PLASMA | 6.59e-04 | 69 | 81 | 4 | M27150 | |
| Pathway | REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS | 7.34e-04 | 71 | 81 | 4 | M1078 | |
| Pathway | REACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION | 7.34e-04 | 71 | 81 | 4 | M27203 | |
| Pathway | REACTOME_METABOLISM_OF_PORPHYRINS | 8.04e-04 | 32 | 81 | 3 | MM14719 | |
| Pubmed | 1.98e-12 | 6 | 113 | 5 | 98179 | ||
| Pubmed | 1.98e-12 | 6 | 113 | 5 | 99744 | ||
| Pubmed | 1.98e-12 | 6 | 113 | 5 | 4691517 | ||
| Pubmed | 6.92e-12 | 7 | 113 | 5 | 9603450 | ||
| Pubmed | 1.99e-09 | 17 | 113 | 5 | 8223863 | ||
| Pubmed | Discovery and refinement of loci associated with lipid levels. | PDXDC1 PDE3A ABCA1 UGT1A5 CYP26A1 TMEM176A CUBN UGT1A4 SLC22A1 | 3.25e-08 | 211 | 113 | 9 | 24097068 |
| Pubmed | Immunoglobulin genes of different subgroups are interdigitated within the VK locus. | 3.34e-08 | 3 | 113 | 3 | 6440122 | |
| Pubmed | 3.32e-07 | 5 | 113 | 3 | 17142808 | ||
| Pubmed | Identification of 18 mouse ABC genes and characterization of the ABC superfamily in Mus musculus. | 8.92e-07 | 23 | 113 | 4 | 10708515 | |
| Pubmed | 1.27e-06 | 105 | 113 | 6 | 30280653 | ||
| Pubmed | 1.85e-06 | 8 | 113 | 3 | 24293640 | ||
| Pubmed | 3.42e-06 | 193 | 113 | 7 | 19343046 | ||
| Pubmed | IMGT/GENE-DB: a comprehensive database for human and mouse immunoglobulin and T cell receptor genes. | 5.43e-06 | 77 | 113 | 5 | 15608191 | |
| Pubmed | 5.74e-06 | 36 | 113 | 4 | 11298326 | ||
| Pubmed | 9.33e-06 | 13 | 113 | 3 | 16403838 | ||
| Pubmed | Transcriptional regulation of telomerase activity: roles of the the Ets transcription factor family. | 1.05e-05 | 2 | 113 | 2 | 17986575 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 8195215 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 26749169 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 2997781 | ||
| Pubmed | Differential expression of ets-1 and ets-2 proto-oncogenes during murine embryogenesis. | 1.05e-05 | 2 | 113 | 2 | 8183549 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 24277931 | ||
| Pubmed | Expression of the lipid transporters ABCA3 and ABCA1 is diminished in human breast cancer tissue. | 1.05e-05 | 2 | 113 | 2 | 19902402 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 28373057 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 21586796 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 25665932 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 8519813 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 11687802 | ||
| Pubmed | ETS-1 and ETS-2 are upregulated in a transgenic mouse model of pigmented ocular neoplasm. | 1.05e-05 | 2 | 113 | 2 | 18958307 | |
| Pubmed | Characterization and localization of the products of the human homologs of the v-ets oncogene. | 1.05e-05 | 2 | 113 | 2 | 3285299 | |
| Pubmed | Ets-1 and Ets-2 protooncogene expression in theca cells of the adult mouse ovary. | 1.05e-05 | 2 | 113 | 2 | 1511734 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 38019257 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 31189668 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 14570867 | ||
| Pubmed | Mammalian ets-1 and ets-2 genes encode highly conserved proteins. | 1.05e-05 | 2 | 113 | 2 | 2847145 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 3019221 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 34910522 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 26365772 | ||
| Pubmed | In vivo modulation of ETS genes induced by electromagnetic fields. | 1.05e-05 | 2 | 113 | 2 | 11887334 | |
| Pubmed | Heterogeneity of high density lipoprotein generated by ABCA1 and ABCA7. | 1.05e-05 | 2 | 113 | 2 | 15930518 | |
| Pubmed | 2.54e-05 | 52 | 113 | 4 | 26590417 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 17203221 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 10375504 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 11279115 | ||
| Pubmed | Cochlear outer hair cell horizontal top connectors mediate mature stereocilia bundle mechanics. | 3.13e-05 | 3 | 113 | 2 | 30801007 | |
| Pubmed | Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer. | 3.13e-05 | 3 | 113 | 2 | 17671502 | |
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 29108785 | ||
| Pubmed | Function of prokaryotic and eukaryotic ABC proteins in lipid transport. | 3.13e-05 | 3 | 113 | 2 | 15749056 | |
| Pubmed | Ets-1 and Ets-2 regulate the expression of microRNA-126 in endothelial cells. | 3.13e-05 | 3 | 113 | 2 | 20671229 | |
| Pubmed | Conserved chromosomal positions of dual domains of the ets protooncogene in cats, mice, and humans. | 3.13e-05 | 3 | 113 | 2 | 3513188 | |
| Pubmed | Sp100 interacts with ETS-1 and stimulates its transcriptional activity. | 3.13e-05 | 3 | 113 | 2 | 11909962 | |
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 21989915 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 18374905 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 1409581 | ||
| Pubmed | Semaphorin 7A initiates T-cell-mediated inflammatory responses through alpha1beta1 integrin. | 3.13e-05 | 3 | 113 | 2 | 17377534 | |
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 8871649 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 5027703 | ||
| Pubmed | ATP-binding cassette transporters ABCA1, ABCA7, and ABCG1 in mouse spermatozoa. | 3.13e-05 | 3 | 113 | 2 | 18793613 | |
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 7689222 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 7609063 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 22403608 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 10377039 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 24097981 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 29558679 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 10212281 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 2163347 | ||
| Pubmed | MicroRNA 17-92 cluster mediates ETS1 and ETS2-dependent RAS-oncogenic transformation. | 3.13e-05 | 3 | 113 | 2 | 24968297 | |
| Pubmed | Examining the role of ABC lipid transporters in pulmonary lipid homeostasis and inflammation. | 3.13e-05 | 3 | 113 | 2 | 28241820 | |
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 15520449 | ||
| Pubmed | 3.13e-05 | 3 | 113 | 2 | 28119415 | ||
| Pubmed | Human metabolic individuality in biomedical and pharmaceutical research. | 3.65e-05 | 57 | 113 | 4 | 21886157 | |
| Pubmed | Stereocilin-deficient mice reveal the origin of cochlear waveform distortions. | 6.25e-05 | 4 | 113 | 2 | 18849963 | |
| Pubmed | 6.25e-05 | 4 | 113 | 2 | 10815800 | ||
| Pubmed | Genetic variations and haplotypes of UDP-glucuronosyltransferase 1A locus in a Korean population. | 6.25e-05 | 4 | 113 | 2 | 18223459 | |
| Pubmed | 6.25e-05 | 4 | 113 | 2 | 20495215 | ||
| Pubmed | SOX9 indirectly regulates CEACAM1 expression and immune resistance in melanoma cells. | 6.25e-05 | 4 | 113 | 2 | 26885752 | |
| Pubmed | EAPII interacts with ETS1 and modulates its transcriptional function. | 6.25e-05 | 4 | 113 | 2 | 12743594 | |
| Pubmed | Advancing precision medicine for prostate cancer through genomics. | 6.25e-05 | 4 | 113 | 2 | 23589550 | |
| Pubmed | 6.25e-05 | 4 | 113 | 2 | 10942770 | ||
| Pubmed | 6.25e-05 | 4 | 113 | 2 | 19721717 | ||
| Pubmed | Transcriptional regulation of the apolipoprotein F (ApoF) gene by ETS and C/EBPα in hepatoma cells. | 6.25e-05 | 4 | 113 | 2 | 25726912 | |
| Pubmed | 6.25e-05 | 4 | 113 | 2 | 10358095 | ||
| Pubmed | The SAM domain of human TEL2 can abrogate transcriptional output from TEL1 (ETV-6) and ETS1/ETS2. | 6.25e-05 | 4 | 113 | 2 | 22615925 | |
| Pubmed | Non-canonical NF-κB signalling and ETS1/2 cooperatively drive C250T mutant TERT promoter activation. | 6.25e-05 | 4 | 113 | 2 | 26389665 | |
| Pubmed | 6.25e-05 | 4 | 113 | 2 | 24145140 | ||
| Pubmed | 6.25e-05 | 4 | 113 | 2 | 10918595 | ||
| Pubmed | 6.25e-05 | 4 | 113 | 2 | 11259414 | ||
| Pubmed | 6.25e-05 | 4 | 113 | 2 | 8981363 | ||
| Pubmed | 6.25e-05 | 4 | 113 | 2 | 17108952 | ||
| Pubmed | 6.25e-05 | 4 | 113 | 2 | 17977828 | ||
| Pubmed | DNHD1 PGAP3 CHRDL2 TNFSF14 GPAT3 ADAM32 OLFML3 POGLUT1 DPEP2 PTCH2 LYNX1 MPZL2 | 8.95e-05 | 985 | 113 | 12 | 12975309 | |
| Pubmed | 1.04e-04 | 5 | 113 | 2 | 8010975 | ||
| Pubmed | Ras/mitogen-activated protein kinase signaling activates Ets-1 and Ets-2 by CBP/p300 recruitment. | 1.04e-04 | 5 | 113 | 2 | 15572696 | |
| Pubmed | 1.04e-04 | 5 | 113 | 2 | 16263717 | ||
| Pubmed | 1.04e-04 | 5 | 113 | 2 | 9334186 | ||
| Pubmed | 1.04e-04 | 5 | 113 | 2 | 12752447 | ||
| Pubmed | 1.04e-04 | 5 | 113 | 2 | 18997172 | ||
| Pubmed | Ets1 and Ets2 are required for endothelial cell survival during embryonic angiogenesis. | 1.04e-04 | 5 | 113 | 2 | 19411629 | |
| Pubmed | 1.04e-04 | 5 | 113 | 2 | 24920589 | ||
| Pubmed | 1.08e-04 | 143 | 113 | 5 | 20424473 | ||
| Pubmed | 1.56e-04 | 6 | 113 | 2 | 2575584 | ||
| Cytoband | 2p12 | IGKV3D-20 IGKV3D-15 IGKV3D-11 IGKV1D-42 IGKV3-20 IGKV3-15 IGKV3-11 IGKV3-7 | 6.13e-10 | 117 | 114 | 8 | 2p12 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2p11 | RNF103 IGKV3D-20 IGKV3D-15 IGKV3D-11 IGKV1D-42 IGKV3-20 IGKV3-15 IGKV3-11 IGKV3-7 | 3.58e-09 | 213 | 114 | 9 | chr2p11 |
| Cytoband | 11q14 | 3.97e-04 | 12 | 114 | 2 | 11q14 | |
| GeneFamily | Immunoglobulin kappa locus at 2p11.2 | IGKV3D-20 IGKV3D-15 IGKV3D-11 IGKV1D-42 IGKV3-20 IGKV3-15 IGKV3-11 IGKV3-7 | 2.80e-09 | 83 | 79 | 8 | 351 |
| GeneFamily | Solute carriers | SLCO4A1 SLC24A3 SLC34A3 SLC10A7 SLC2A3 SLC5A3 SLC6A9 SLC8A2 SLC16A5 SLC45A3 SLC22A1 SLC37A4 | 1.37e-07 | 395 | 79 | 12 | 752 |
| GeneFamily | ATP binding cassette subfamily A | 2.82e-05 | 14 | 79 | 3 | 805 | |
| GeneFamily | Olfactory receptors, family 56 | 6.65e-04 | 9 | 79 | 2 | 167 | |
| GeneFamily | ATP binding cassette subfamily C | 1.43e-03 | 13 | 79 | 2 | 807 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.67e-03 | 394 | 79 | 7 | 471 | |
| GeneFamily | Carboxypeptidases | 3.75e-03 | 21 | 79 | 2 | 1321 | |
| GeneFamily | G protein-coupled receptors, Class A orphans | 4.83e-03 | 78 | 79 | 3 | 262 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 5.66e-03 | 163 | 79 | 4 | 590 | |
| GeneFamily | ETS transcription factor family | 6.62e-03 | 28 | 79 | 2 | 534 | |
| GeneFamily | UDP glucuronosyltransferases | 8.59e-03 | 32 | 79 | 2 | 363 | |
| Coexpression | GSE35543_IN_VIVO_NTREG_VS_CONVERTED_EX_ITREG_DN | 2.32e-06 | 199 | 112 | 8 | M9434 | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | SLC6A9 ASPM IGKV3D-20 IGKV3D-15 IGKV3D-11 IGKV3-20 IGKV3-15 IGKV3-11 IGKV3-7 | 8.37e-10 | 177 | 114 | 9 | 4c434a7b7cc54cf4dac996bbc3f5124d9ef9a9cd |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | SLC6A9 ASPM IGKV3D-20 IGKV3D-15 IGKV3D-11 IGKV3-20 IGKV3-15 IGKV3-11 IGKV3-7 | 8.37e-10 | 177 | 114 | 9 | d746122bf8d208c3aa4d156e8c12d0a0e555c6e5 |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | SLC6A9 ASPM IGKV3D-20 IGKV3D-15 IGKV3D-11 IGKV3-20 IGKV3-15 IGKV3-11 IGKV3-7 | 8.37e-10 | 177 | 114 | 9 | fc40918825b7e1eb6861df59dfca944778a64b98 |
| ToppCell | healthy_donor-Lymphocytic-Plasma_cell-IgA_Plasmablast|healthy_donor / Disease condition, Lineage, Cell class and subclass | SLC6A9 IGKV3D-20 IGKV3D-15 IGKV3D-11 IGKV1D-42 IGKV3-20 IGKV3-15 IGKV3-11 IGKV3-7 | 1.30e-09 | 186 | 114 | 9 | e2c050ba02e1f84f0b7258dc92e7ff6ab349ff67 |
| ToppCell | healthy_donor-Lymphocytic-Plasma_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | SLC6A9 IGKV3D-20 IGKV3D-15 IGKV3D-11 IGKV1D-42 IGKV3-20 IGKV3-15 IGKV3-11 IGKV3-7 | 1.42e-09 | 188 | 114 | 9 | bd53b0371154cff680226897b61c9809a239d1b6 |
| ToppCell | Biopsy_IPF-Immune-Plasma_cells|Biopsy_IPF / Sample group, Lineage and Cell type | TAS1R3 ASPM IGKV3D-20 IGKV3D-15 IGKV3D-11 IGKV3-20 IGKV3-15 IGKV3-11 IGKV3-7 | 2.05e-09 | 196 | 114 | 9 | a1b6a8000b86efcb07843998aa3a49bb1f54bcda |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Mast_cell-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.24e-09 | 198 | 114 | 9 | cc5ca64749e2f4f1d373d9472824df85741702b7 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.24e-09 | 198 | 114 | 9 | d4d66f19df078bfc3a83d4664aaf9c7789bde1a5 | |
| ToppCell | Control-Lymphoid_P-Plasmablast|Control / Disease group, lineage and cell class | IGKV3D-20 IGKV3D-15 IGKV3D-11 IGKV1D-42 IGKV3-20 IGKV3-15 IGKV3-11 IGKV3-7 | 1.81e-08 | 176 | 114 | 8 | 4b4416f342b732d2cc60133838728880326257d8 |
| ToppCell | Control-Lymphoid_P|Control / Disease group, lineage and cell class | IGKV3D-20 IGKV3D-15 IGKV3D-11 IGKV1D-42 IGKV3-20 IGKV3-15 IGKV3-11 IGKV3-7 | 1.81e-08 | 176 | 114 | 8 | d895a6b295cd649273ff80ad7785a3e0ae4c728a |
| ToppCell | (2)_Plasma_cells|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | TAS1R3 IGKV3D-20 IGKV3D-15 IGKV3D-11 IGKV3-20 IGKV3-15 IGKV3-11 IGKV3-7 | 1.89e-08 | 177 | 114 | 8 | ed3c936bb69f9bc7291b4f6cde1d204078117c48 |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | TAS1R3 IGKV3D-20 IGKV3D-15 IGKV3D-11 IGKV3-20 IGKV3-15 IGKV3-11 IGKV3-7 | 2.25e-08 | 181 | 114 | 8 | e47664a264a2c37390d1668ce04eef2e0172f4cb |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.55e-08 | 192 | 114 | 8 | 60a02e0ccdc8c7af9bc875b248467304fe0d24a4 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.55e-08 | 192 | 114 | 8 | b223fca73e16668f69a78cf4457e349d01792540 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.55e-08 | 192 | 114 | 8 | b5615a780b0ba24a8e554fac9238d3f0bcba52bc | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid_mast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.55e-08 | 192 | 114 | 8 | 5532ea1bc012eb9303197b87e90bc39619b5ee2a | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.70e-08 | 193 | 114 | 8 | c17e87c042ef095ac99fdd6facf3bc2886924dc4 | |
| ToppCell | Biopsy_Other_PF-Immune-Plasma_cells|Biopsy_Other_PF / Sample group, Lineage and Cell type | TAS1R3 IGKV3D-20 IGKV3D-15 IGKV3D-11 IGKV3-20 IGKV3-15 IGKV3-11 IGKV3-7 | 4.01e-08 | 195 | 114 | 8 | d0305c6a68c9e361507b04db94f86873085d49b3 |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | TAS1R3 IGKV3D-20 IGKV3D-15 IGKV3D-11 IGKV3-20 IGKV3-15 IGKV3-11 IGKV3-7 | 4.17e-08 | 196 | 114 | 8 | c38e7f533c619afe008de0e99042f7180c2da918 |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | TAS1R3 IGKV3D-20 IGKV3D-15 IGKV3D-11 IGKV3-20 IGKV3-15 IGKV3-11 IGKV3-7 | 4.17e-08 | 196 | 114 | 8 | fec21383435779bf4c632decd3d29c6ca7baebfb |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Mast_cell|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.87e-08 | 200 | 114 | 8 | c3511607692e05f44538a376253673dd18f77908 | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Mast_cell-Mast_cell|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.87e-08 | 200 | 114 | 8 | 1c58860932ed47263a5a537a64f0343201463c21 | |
| ToppCell | healthy_donor-Lymphocytic-Plasma_cell-IgG_Plasmablast|healthy_donor / Disease condition, Lineage, Cell class and subclass | TAS1R3 IGKV3D-20 IGKV3D-15 IGKV3D-11 IGKV3-20 IGKV3-15 IGKV3-11 | 1.33e-07 | 152 | 114 | 7 | a2ba2d95ac9010e1a62db34dcad10d004f8a90cc |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Granulocytic-Mast_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.89e-07 | 160 | 114 | 7 | fe9970c160159b35f6599ed13c89cfb49264d554 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_dendritic-plasmacytoid_dendritic_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.52e-07 | 167 | 114 | 7 | afb6d0993f3fd44a295874673055189d514f7b11 | |
| ToppCell | Control-Lymphoid-B_Plasma|Control / Disease state, Lineage and Cell class | IGKV3D-20 IGKV3D-15 IGKV3D-11 IGKV3-20 IGKV3-15 IGKV3-11 IGKV3-7 | 3.08e-07 | 172 | 114 | 7 | 61e33836b8cb0f347f3e699eb587a37073b6fa4c |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGKV3D-20 IGKV3D-15 IGKV3D-11 IGKV3-20 IGKV3-15 IGKV3-11 IGKV3-7 | 3.20e-07 | 173 | 114 | 7 | 7e6bfe85f60834f317941b70d6e0dc3bd527d293 |
| ToppCell | COPD-Lymphoid-B_Plasma|World / Disease state, Lineage and Cell class | IGKV3D-20 IGKV3D-15 IGKV3D-11 IGKV3-20 IGKV3-15 IGKV3-11 IGKV3-7 | 3.46e-07 | 175 | 114 | 7 | d73ee324479172501481b54967a0f3bd870fcf3a |
| ToppCell | IPF-Lymphoid-B_Plasma|IPF / Disease state, Lineage and Cell class | IGKV3D-20 IGKV3D-15 IGKV3D-11 IGKV3-20 IGKV3-15 IGKV3-11 IGKV3-7 | 3.60e-07 | 176 | 114 | 7 | e4f33f6cd140dd4fa3002bcd65ac8005d27865d1 |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | IGKV3D-20 IGKV3D-15 IGKV3D-11 IGKV3-20 IGKV3-15 IGKV3-11 IGKV3-7 | 4.03e-07 | 179 | 114 | 7 | 837ed81f18257f444eaeadc4fac89deedd4e3061 |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | SLC6A9 IGKV3D-20 IGKV3D-15 IGKV3D-11 IGKV3-20 IGKV3-15 IGKV3-11 | 4.03e-07 | 179 | 114 | 7 | 494febe77c6d4e6a2c6f0928bbf4c84b0301f188 |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | IGKV3D-20 IGKV3D-15 IGKV3D-11 IGKV3-20 IGKV3-15 IGKV3-11 IGKV3-7 | 4.03e-07 | 179 | 114 | 7 | b6ee4f41d8fb5f047b7bdd8489dda0a89fc6d43f |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | TAS1R3 IGKV3D-20 IGKV3D-15 IGKV3D-11 IGKV3-20 IGKV3-15 IGKV3-11 | 4.68e-07 | 183 | 114 | 7 | cf5c98f451a568308c52da5c926543dd4836c6b2 |
| ToppCell | 10x5'-Liver-Lymphocytic_B_plasma-Plasma_cells|Liver / Manually curated celltypes from each tissue | 4.86e-07 | 184 | 114 | 7 | 6f70d8f8ab8362d51f8a58735d42223e06566397 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | TAS1R3 IGKV3D-20 IGKV3D-15 IGKV3D-11 IGKV3-20 IGKV3-15 IGKV3-11 | 5.04e-07 | 185 | 114 | 7 | 6ec009e48e50471c28e914c402f500e56a88f8f2 |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | TAS1R3 IGKV3D-20 IGKV3D-15 IGKV3D-11 IGKV3-20 IGKV3-15 IGKV3-11 | 5.04e-07 | 185 | 114 | 7 | f49ad6401b2abd089e30eba245b11b5031ea2318 |
| ToppCell | (4)_Mast_cells|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.04e-07 | 185 | 114 | 7 | c91e1081e630a61c18f6af6d198bfcf296746852 | |
| ToppCell | (4)_Mast_cells|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.04e-07 | 185 | 114 | 7 | 3dd5d2237ab50b13a41c12f85e1b79cd72ea567b | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | TAS1R3 IGKV3D-20 IGKV3D-15 IGKV3D-11 IGKV3-20 IGKV3-15 IGKV3-11 | 5.04e-07 | 185 | 114 | 7 | 08bc817908076734d66f2805cb954141f2cc5a18 |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | TAS1R3 IGKV3D-20 IGKV3D-15 IGKV3D-11 IGKV3-20 IGKV3-15 IGKV3-11 | 5.04e-07 | 185 | 114 | 7 | 1704a12153a9b107bf03ecccd1a036cf61334d7a |
| ToppCell | IPF-Lymphoid-B_Plasma|Lymphoid / Disease state, Lineage and Cell class | ASPM IGKV3D-20 IGKV3D-15 IGKV3D-11 IGKV3-20 IGKV3-15 IGKV3-11 | 5.22e-07 | 186 | 114 | 7 | f9c21daf905d0bb0e0e769ca4bb069ea4b1ba25b |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.22e-07 | 186 | 114 | 7 | acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.82e-07 | 189 | 114 | 7 | f01158bb15df3117fae1271bf8cf8c2501422671 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | IGKV3D-20 IGKV3D-15 IGKV3D-11 IGKV3-20 IGKV3-15 IGKV3-11 IGKV3-7 | 6.03e-07 | 190 | 114 | 7 | 79ee6d10dfbb775da149a1104da5823cf63bbb46 |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | IGKV3D-20 IGKV3D-15 IGKV3D-11 IGKV3-20 IGKV3-15 IGKV3-11 IGKV3-7 | 6.03e-07 | 190 | 114 | 7 | 18762ce78ed0b206ade19e1c8ff76a2647489f68 |
| ToppCell | 390C-Myeloid-Mast_cell-|390C / Donor, Lineage, Cell class and subclass (all cells) | 6.24e-07 | 191 | 114 | 7 | 88bcd0b85b2112cef15c9e44d1429f9fba4a3400 | |
| ToppCell | 390C-Myeloid-Mast_cell|390C / Donor, Lineage, Cell class and subclass (all cells) | 6.24e-07 | 191 | 114 | 7 | c1517ea7b10a7f732725b4c0224fbfecae80d18b | |
| ToppCell | cellseq-Immune-Hematopoietic-Granulocytic-Mast/Basophil|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.46e-07 | 192 | 114 | 7 | b29d6b4bed4d55060586276973732461538752df | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV3D-20 IGKV3D-15 IGKV3D-11 IGKV3-20 IGKV3-15 IGKV3-11 IGKV3-7 | 6.69e-07 | 193 | 114 | 7 | 34f6c13884fdf7f8a87f942fcb36a58cfac3f65d |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV3D-20 IGKV3D-15 IGKV3D-11 IGKV3-20 IGKV3-15 IGKV3-11 IGKV3-7 | 6.69e-07 | 193 | 114 | 7 | 282b47dae6043eabb1e13d41d91c07b5ec21cd65 |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV3D-20 IGKV3D-15 IGKV3D-11 IGKV3-20 IGKV3-15 IGKV3-11 IGKV3-7 | 6.93e-07 | 194 | 114 | 7 | 6ef4aeb8d8e35e4df58ff2a8256caa2113291de9 |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells-IgG_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | IGKV3D-20 IGKV3D-15 IGKV3D-11 IGKV3-20 IGKV3-15 IGKV3-11 IGKV3-7 | 6.93e-07 | 194 | 114 | 7 | f083777353e76a2d9c39f8b6cb1a689b68b81c56 |
| ToppCell | COVID_vent-Lymphocytic-Plasma_cell-IgM_Plasmablast|COVID_vent / Disease condition, Lineage, Cell class and subclass | RPN2 IGKV3D-20 IGKV3D-15 IGKV3D-11 IGKV3-20 IGKV3-15 IGKV3-11 | 7.42e-07 | 196 | 114 | 7 | 026a06d8d2089806823e6f6453d3ede84ae93bc6 |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Mast_cell-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.68e-07 | 197 | 114 | 7 | bed8a9b73af5caee51b1232b31c24a59353658df | |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-B|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV3D-20 IGKV3D-15 IGKV3D-11 IGKV3-20 IGKV3-15 IGKV3-11 IGKV3-7 | 7.68e-07 | 197 | 114 | 7 | 2662138671262b30508c5759038bcdcfe6551696 |
| ToppCell | COVID_non-vent-Lymphocytic-Plasma_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 7.68e-07 | 197 | 114 | 7 | 1e63879633f20646e44873ae6b662f6faf4806fd | |
| ToppCell | COVID_non-vent-Lymphocytic-Plasma_cell-IgG_Plasmablast|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 7.68e-07 | 197 | 114 | 7 | b754fad4f3caae6de95df901fd96ea8697fe41b1 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.68e-07 | 197 | 114 | 7 | b7d5073d44aa1e2cb83ea8d8104c5ed662665755 | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV3D-20 IGKV3D-15 IGKV3D-11 IGKV3-20 IGKV3-15 IGKV3-11 IGKV3-7 | 7.68e-07 | 197 | 114 | 7 | 9fe1b757f76c2d43d39aa9ac500eaba98723985c |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_alveolar|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 8.22e-07 | 199 | 114 | 7 | 7ebd89dff457f57a549eecee288c7a4b515b4018 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Mast_cell-Mast_cell|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.50e-07 | 200 | 114 | 7 | 8943278190f42016ee914e584d1b6b9aeaf7c73f | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Mast_cell|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.50e-07 | 200 | 114 | 7 | ea52df18400550b65de142d03b3b0963436e03d9 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.58e-06 | 160 | 114 | 6 | bb1bb3673059768c0ea0160d29fff127f3a4ecb4 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.58e-06 | 160 | 114 | 6 | 76f49b8b4450fa8acd36326bfa36a5d1f4bd95fb | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.71e-06 | 161 | 114 | 6 | e227f7b711475624cf80e77f235b1783d88d57b4 | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.71e-06 | 161 | 114 | 6 | 8280a029026c272cae9649b27575831b0dd4e242 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-neutrophil|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.84e-06 | 162 | 114 | 6 | 9c9a63adb692651ea5a52cc77b02c5ce11d0ccea | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.84e-06 | 162 | 114 | 6 | dddf7a3901ae59e3494d8a6740db0fa15cc96d47 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-neutrophil-neutrophil|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.84e-06 | 162 | 114 | 6 | 1d29983b22f963b34e72cfd1eec328d2d7c4932f | |
| ToppCell | 368C-Lymphocytic-Plasma_cell-|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.84e-06 | 162 | 114 | 6 | c21a54310b239d999bbc9d8fb5e8fda16e0bc336 | |
| ToppCell | 368C-Lymphocytic-Plasma_cell|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.84e-06 | 162 | 114 | 6 | f945688815229c8386cbcbf46deee7df316fa8d3 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.84e-06 | 162 | 114 | 6 | 2a4e09545e9874519f0f56e81065104987d81cd6 | |
| ToppCell | droplet-Heart-4Chambers-18m-Myeloid-cardiac_mast_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.27e-06 | 165 | 114 | 6 | a761e0a36d5da8fec916d684f81e60f5590fd9ee | |
| ToppCell | droplet-Heart-4Chambers-18m-Myeloid-mast_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.27e-06 | 165 | 114 | 6 | 680bdd150bc0a4e50244e57b1226a9b06a6bdbc9 | |
| ToppCell | droplet-Heart-4Chambers-18m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.27e-06 | 165 | 114 | 6 | af423307af484661284793a08091777d998e6fba | |
| ToppCell | 367C-Lymphocytic-Plasma_cell-|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.58e-06 | 167 | 114 | 6 | f2185eb72f0137136f6d71af2a70168fded6c940 | |
| ToppCell | 367C-Lymphocytic-Plasma_cell|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.58e-06 | 167 | 114 | 6 | 5e768cf24699893e05d1bcb1c92dba2336943a64 | |
| ToppCell | Control-Mast_cells|Control / group, cell type (main and fine annotations) | 4.90e-06 | 169 | 114 | 6 | fdb9abca1d0f4fdc32dd8ac6231651ef34aa5afb | |
| ToppCell | Control-Lymphoid-B_Plasma|World / Disease state, Lineage and Cell class | 5.07e-06 | 170 | 114 | 6 | fb05f49b7113470995b3c16683c54dc1a660b73a | |
| ToppCell | Control-Mast_cells-Mast_cells|Control / group, cell type (main and fine annotations) | 5.07e-06 | 170 | 114 | 6 | c80f6d29096c372da95a8407f402349ff1bb7018 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5+_undifferentiated_cell_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.07e-06 | 170 | 114 | 6 | 833b4f44ea1fa673dfc6b43ce45a79fe68ae3b05 | |
| ToppCell | Plasma_cells|World / lung cells shred on cell class, cell subclass, sample id | 5.60e-06 | 173 | 114 | 6 | 52a387e2a4694af61a9223a4c2ecf4e6f762c064 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B_plasma-Plasma_cells|bone_marrow / Manually curated celltypes from each tissue | 5.99e-06 | 175 | 114 | 6 | 51301f3f44d3e88397f367cedd1e2abaa2be4c6f | |
| ToppCell | metastatic_Brain-B_lymphocytes-MALT_B_cells|metastatic_Brain / Location, Cell class and cell subclass | 6.18e-06 | 176 | 114 | 6 | 50e207403d48ce1b55a78897adb5519a2430a626 | |
| ToppCell | IPF-Lymphoid-B_Plasma|World / Disease state, Lineage and Cell class | 6.18e-06 | 176 | 114 | 6 | cc0cab6487df6867b529596ec94f55d31aa6ca36 | |
| ToppCell | COVID-19-kidney-PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.03e-06 | 180 | 114 | 6 | 493cf8d1a8f2a1ed2672f394a0338b110fd81d88 | |
| ToppCell | NS-moderate-d_0-4-Lymphoid-CTL|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.26e-06 | 181 | 114 | 6 | 7fb3c1d29c542a3cea7fa654432d501d82df138f | |
| ToppCell | 10x5'-bone_marrow-Mast-Mast_cell_lympho|bone_marrow / Manually curated celltypes from each tissue | 7.26e-06 | 181 | 114 | 6 | 56fa77ae31f3b7de6e441a439c33a11353b6573a | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.26e-06 | 181 | 114 | 6 | 1db1eb7d330a7e5090994007ae287e11f0a74450 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.26e-06 | 181 | 114 | 6 | 06174ce9240c9261c0f51a1b0d875335d60722e5 | |
| ToppCell | metastatic_Lymph_Node-B_lymphocytes-Plasma_cells|B_lymphocytes / Location, Cell class and cell subclass | 7.49e-06 | 182 | 114 | 6 | 27d1688fdfc570cedd233aa7030bce7d9b604d42 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_granulocytic-mast_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.73e-06 | 183 | 114 | 6 | 5ac38a2ce93c53f23a89faf287b81ea138560623 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.73e-06 | 183 | 114 | 6 | 8b7f9e55c21c99395c71c5ac4f5db0f6c5733ef9 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.73e-06 | 183 | 114 | 6 | 03c7e69136d5a3b9c5b2c91733e9b1c791f45c49 | |
| ToppCell | cellseq-Immune-Lymphocytic_B-Lymphocytic_B-Plasma|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.73e-06 | 183 | 114 | 6 | 5ab4aa0304b832f98fff89b6c24ad5b7dd014c11 | |
| ToppCell | Mild_COVID-19-B_cell|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 7.73e-06 | 183 | 114 | 6 | dea119e2988e954475f557f0bbe12556a83e81a4 | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_neutrophil-granulo-eo/baso/mast-basophil|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.73e-06 | 183 | 114 | 6 | f9a3af96c0fb7d5c4d7df6db8b2c42e322418c08 | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.97e-06 | 184 | 114 | 6 | 9c20b50f8d6ac689d41d5440c835f9db8d04758b | |
| ToppCell | IPF-Myeloid-Mast|World / Disease state, Lineage and Cell class | 7.97e-06 | 184 | 114 | 6 | 7aefa182acad5a53c730945fec85329d7168606a | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.97e-06 | 184 | 114 | 6 | 31dbe6119a3bcd266ae5e9b340c853d9ff680dce | |
| Drug | 9-OH-risperidone | 1.82e-06 | 19 | 109 | 4 | CID000475100 | |
| Drug | probenecid | 2.14e-06 | 123 | 109 | 7 | CID000004911 | |
| Drug | sulfinpyrazone | 3.86e-06 | 87 | 109 | 6 | CID000005342 | |
| Disease | autosomal recessive nonsyndromic deafness 16 (implicated_via_orthology) | 1.23e-05 | 2 | 104 | 2 | DOID:0110471 (implicated_via_orthology) | |
| Disease | neutropenia (implicated_via_orthology) | 2.55e-04 | 7 | 104 | 2 | DOID:1227 (implicated_via_orthology) | |
| Disease | X-11793--oxidized bilirubin measurement | 3.40e-04 | 8 | 104 | 2 | EFO_0021260 | |
| Disease | Succinimide measurement | 3.40e-04 | 8 | 104 | 2 | EFO_0022118 | |
| Disease | X-11530 measurement | 3.40e-04 | 8 | 104 | 2 | EFO_0021249 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 3.40e-04 | 8 | 104 | 2 | EFO_0801034 | |
| Disease | cholelithiasis, bilirubin measurement | 3.40e-04 | 8 | 104 | 2 | EFO_0004570, EFO_0004799 | |
| Disease | X-11522 measurement | 3.40e-04 | 8 | 104 | 2 | EFO_0800696 | |
| Disease | X-10458 measurement | 3.40e-04 | 8 | 104 | 2 | EFO_0800692 | |
| Disease | X-24849 measurement | 3.40e-04 | 8 | 104 | 2 | EFO_0800909 | |
| Disease | arylsulfatase K measurement | 3.40e-04 | 8 | 104 | 2 | EFO_0801395 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 3.40e-04 | 8 | 104 | 2 | EFO_0802740 | |
| Disease | X-16946 measurement | 3.40e-04 | 8 | 104 | 2 | EFO_0800766 | |
| Disease | lipid measurement, intermediate density lipoprotein measurement | 3.77e-04 | 96 | 104 | 4 | EFO_0004529, EFO_0008595 | |
| Disease | total cholesterol measurement, intermediate density lipoprotein measurement | 4.24e-04 | 99 | 104 | 4 | EFO_0004574, EFO_0008595 | |
| Disease | phospholipid measurement, intermediate density lipoprotein measurement | 4.24e-04 | 99 | 104 | 4 | EFO_0004639, EFO_0008595 | |
| Disease | X-11442 measurement | 4.36e-04 | 9 | 104 | 2 | EFO_0021236 | |
| Disease | X-11441 measurement | 4.36e-04 | 9 | 104 | 2 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 4.36e-04 | 9 | 104 | 2 | EFO_0004739 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 4.36e-04 | 9 | 104 | 2 | EFO_0801037 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 4.36e-04 | 9 | 104 | 2 | EFO_0801036 | |
| Disease | X-11880 measurement | 4.36e-04 | 9 | 104 | 2 | EFO_0800698 | |
| Disease | protein-tyrosine kinase 6 measurement | 4.36e-04 | 9 | 104 | 2 | EFO_0020691 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 4.36e-04 | 9 | 104 | 2 | EFO_0802127 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 4.36e-04 | 9 | 104 | 2 | EFO_0004570, GO_0009410 | |
| Disease | free cholesterol measurement, intermediate density lipoprotein measurement | 5.11e-04 | 104 | 104 | 4 | EFO_0008591, EFO_0008595 | |
| Disease | bilirubin measurement, response to tenofovir | 5.44e-04 | 10 | 104 | 2 | EFO_0004570, EFO_0009279 | |
| Disease | X-21448 measurement | 5.44e-04 | 10 | 104 | 2 | EFO_0800816 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 5.44e-04 | 10 | 104 | 2 | EFO_0802185 | |
| Disease | X-23974 measurement | 5.44e-04 | 10 | 104 | 2 | EFO_0800867 | |
| Disease | pregnenetriol sulfate measurement | 6.63e-04 | 11 | 104 | 2 | EFO_0800586 | |
| Disease | plasma N-desmethylclozapine measurement | 6.63e-04 | 11 | 104 | 2 | EFO_0600039 | |
| Disease | histidine betaine (hercynine) measurement | 6.63e-04 | 11 | 104 | 2 | EFO_0800972 | |
| Disease | X-21796 measurement | 6.63e-04 | 11 | 104 | 2 | EFO_0800825 | |
| Disease | insomnia, bilirubin measurement | 6.63e-04 | 11 | 104 | 2 | EFO_0004570, EFO_0004698 | |
| Disease | Cystic Kidney Diseases | 6.63e-04 | 11 | 104 | 2 | C1691228 | |
| Disease | aldosterone measurement | 6.63e-04 | 11 | 104 | 2 | EFO_0010219 | |
| Disease | p-cresol glucuronide measurement | 7.94e-04 | 12 | 104 | 2 | EFO_0800079 | |
| Disease | biliverdin measurement | 7.94e-04 | 12 | 104 | 2 | EFO_0021033 | |
| Disease | pregnenetriol disulfate measurement | 9.36e-04 | 13 | 104 | 2 | EFO_0800587 | |
| Disease | retinol dehydrogenase 16 measurement | 9.36e-04 | 13 | 104 | 2 | EFO_0802007 | |
| Disease | hippocampal atrophy | 1.03e-03 | 56 | 104 | 3 | EFO_0005039 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 1.11e-03 | 128 | 104 | 4 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 1.11e-03 | 128 | 104 | 4 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 1.11e-03 | 128 | 104 | 4 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 1.11e-03 | 128 | 104 | 4 | C1306837 | |
| Disease | Renal Cell Carcinoma | 1.11e-03 | 128 | 104 | 4 | C0007134 | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 1.21e-03 | 224 | 104 | 5 | EFO_0004530, EFO_0008317 | |
| Disease | Waxy flexibility | 1.25e-03 | 15 | 104 | 2 | C0233612 | |
| Disease | Catalepsy | 1.25e-03 | 15 | 104 | 2 | C0007370 | |
| Disease | unipolar depression, response to escitalopram, response to citalopram, mood disorder | 1.25e-03 | 15 | 104 | 2 | EFO_0003761, EFO_0004247, EFO_0006329, EFO_0007871 | |
| Disease | Alzheimer disease, Cognitive impairment | 1.25e-03 | 15 | 104 | 2 | HP_0100543, MONDO_0004975 | |
| Disease | free cholesterol in HDL measurement | 1.32e-03 | 61 | 104 | 3 | EFO_0022264 | |
| Disease | succinylcarnitine measurement | 1.43e-03 | 16 | 104 | 2 | EFO_0020020 | |
| Disease | muscular dystrophy (is_implicated_in) | 1.62e-03 | 17 | 104 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 1.62e-03 | 17 | 104 | 2 | EFO_0004611, EFO_0007800 | |
| Disease | extrahepatic cholestasis (biomarker_via_orthology) | 1.62e-03 | 17 | 104 | 2 | DOID:13619 (biomarker_via_orthology) | |
| Disease | X-21441 measurement | 1.62e-03 | 17 | 104 | 2 | EFO_0800814 | |
| Disease | angiopoietin-related protein 1 measurement | 1.81e-03 | 18 | 104 | 2 | EFO_0801382 | |
| Disease | level of Phosphatidylcholine (15:0_18:2) in blood serum | 1.81e-03 | 18 | 104 | 2 | OBA_2045065 | |
| Disease | serum metabolite measurement | PDXDC1 ABCC1 PDE3A UGT1A5 SLC24A3 ABCA7 OLFML3 UGT1A4 SLC22A1 ALK | 1.87e-03 | 945 | 104 | 10 | EFO_0005653 |
| Disease | cholesterol in very large HDL measurement | 1.88e-03 | 69 | 104 | 3 | EFO_0022229 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 1.89e-03 | 148 | 104 | 4 | C0279702 | |
| Disease | level of Sterol ester (27:1/20:3) in blood serum | 2.02e-03 | 19 | 104 | 2 | OBA_2045199 | |
| Disease | phospholipids in large HDL measurement | 2.21e-03 | 73 | 104 | 3 | EFO_0022190 | |
| Disease | total lipids in large HDL | 2.30e-03 | 74 | 104 | 3 | EFO_0022189 | |
| Disease | tissue factor measurement | 2.47e-03 | 21 | 104 | 2 | EFO_0010623 | |
| Disease | carnitine measurement | 2.48e-03 | 76 | 104 | 3 | EFO_0010469 | |
| Disease | creatinine measurement | SEMA7A CYP26A1 ETS1 SLC34A3 CUBN HNF4G AP4E1 SLC22A1 UMOD ABCC10 | 2.72e-03 | 995 | 104 | 10 | EFO_0004518 |
| Disease | citrate measurement | 2.77e-03 | 79 | 104 | 3 | EFO_0010114 | |
| Disease | free cholesterol in large HDL measurement | 2.77e-03 | 79 | 104 | 3 | EFO_0022157 | |
| Disease | cholesterol in large HDL measurement | 2.87e-03 | 80 | 104 | 3 | EFO_0021900 | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 2.87e-03 | 166 | 104 | 4 | EFO_0004530, EFO_0004611 | |
| Disease | triglyceride measurement, high density lipoprotein cholesterol measurement | 2.90e-03 | 274 | 104 | 5 | EFO_0004530, EFO_0004612 | |
| Disease | response to clopidogrel, cardiovascular event measurement | 2.97e-03 | 23 | 104 | 2 | EFO_0006919, GO_1903493 | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 2.99e-03 | 276 | 104 | 5 | EFO_0004612, EFO_0020943 | |
| Disease | cystatin C measurement | 3.05e-03 | 402 | 104 | 6 | EFO_0004617 | |
| Disease | high density lipoprotein particle size measurement | 3.13e-03 | 170 | 104 | 4 | EFO_0008592 | |
| Disease | hormone measurement | 3.30e-03 | 84 | 104 | 3 | EFO_0004730 | |
| Disease | lipoprotein measurement, phospholipid measurement | 3.41e-03 | 85 | 104 | 3 | EFO_0004639, EFO_0004732 | |
| Disease | Colorectal Carcinoma | 3.43e-03 | 702 | 104 | 8 | C0009402 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| WLLLPSLSLLLFEVA | 11 | Q86WK6 | |
| LALILFLFALSWLPL | 236 | P30542 | |
| PVLALLLLLYGWSIT | 1736 | O95477 | |
| LLWDLISFLIPSLLL | 1146 | Q99758 | |
| TLLLLLLYGWAIIPL | 1181 | Q99758 | |
| NTWLLGFLIALPILI | 681 | Q8TC27 | |
| LEEAVWLDGLSLLPL | 206 | Q96M86 | |
| RLVLGFLWPLLTLTI | 206 | P21730 | |
| LLSYNPLWLRIGLET | 816 | Q8IZT6 | |
| LPALLLLLLLYGWSI | 1616 | Q8IZY2 | |
| PWLQIQLLRILGLLG | 271 | Q9UPM8 | |
| LAPLLSGLFVLWLCI | 411 | Q6ZVN8 | |
| GIFNWLTVLVLLPLE | 196 | Q8N130 | |
| PLLILFLLSWSGPLQ | 6 | Q9NRN5 | |
| LWVALPLLSLLAGSL | 6 | Q9UK05 | |
| LFWPTFLLTGGLLII | 161 | Q16558 | |
| QLLFLLLLWLPDTTG | 6 | A0A0A0MRZ8 | |
| LWLLLFLLPSAQGRQ | 11 | Q8NBL1 | |
| PQLLLSLLLSVWLSK | 766 | Q9H2M9 | |
| AWGLPLQLAITLYLL | 401 | Q5T3U5 | |
| FLQLLSITPINEWLL | 91 | Q0GE19 | |
| LALLWIVPLTLSGLL | 31 | P58400 | |
| VPGLSIWTDLLLALR | 341 | Q9NPI8 | |
| QLLFLLLLWLPDTTG | 6 | A0A0C4DH25 | |
| NWAFLVLPSLLILLL | 226 | Q8IU57 | |
| PLFLLFLDATWQLLE | 461 | Q9NXD2 | |
| WPRLGLQLQFAALLL | 11 | Q76MJ5 | |
| LVVTLWLLLGNLFPL | 631 | Q96KR4 | |
| GSGPIQLWQFLLELL | 331 | P14921 | |
| LSPWLQPSALLFSLL | 126 | Q14432 | |
| LRALPLWLSLQYLGL | 336 | Q6P996 | |
| RALPLWLSLQYLGLD | 336 | Q6P474 | |
| GPIQLWQFLLELLSD | 361 | P15036 | |
| LLLLLLSFLAPWATI | 6 | P42785 | |
| WDTVFLVALLLLGLP | 31 | Q8TDT2 | |
| LLLLGIQLTALWPIA | 11 | O60487 | |
| QLLFLLLLWLPDTTG | 6 | A0A087WSY6 | |
| RVLSSLLGLALLWFP | 6 | Q6WN34 | |
| PLWVILLSAFAGLLL | 1141 | P56199 | |
| ALLPTFSWPQLFLLL | 156 | Q96ES6 | |
| GELLLLLPTLQSITW | 286 | Q14541 | |
| FDILIGLGLPWALQT | 551 | Q9HC58 | |
| ILLGIPGLESFQLWI | 16 | Q8NGF1 | |
| HWLSLPLTLLYLLAL | 31 | Q8NH76 | |
| LPFLWSLLTLLIFAE | 6 | O60494 | |
| TLQELLLSPYLWVLS | 216 | O43826 | |
| LWLGLLLPLVAALDF | 6 | P14384 | |
| LSTWLTLVLGFILLP | 11 | Q53EU6 | |
| VRVPWQGLLLTASLL | 11 | P13688 | |
| SALLWLLLLGTSLSP | 51 | Q7Z3S7 | |
| LSTLLGVPLALLWGF | 76 | P56539 | |
| WAALIILLLPGSLEE | 11 | Q99062 | |
| TLALAPILLATLWGL | 101 | P0DP58 | |
| TFGRWPLLSLLLLLL | 11 | Q9H4A9 | |
| FILGSEELWPLLLGF | 176 | P11169 | |
| VLEGLWLGLTFLLPV | 426 | Q68CP4 | |
| QLLFLLLLWLPDTTG | 6 | P04433 | |
| QLLFLLLLWLPDTTG | 6 | P01624 | |
| QLLFLLLLWLPDTTG | 6 | P01619 | |
| QLLFLLLLWLPDTTR | 6 | A0A075B6H7 | |
| WLLLFNSILPFPDLL | 446 | Q5D0E6 | |
| LPLLLFLAAIKLWDL | 16 | O43174 | |
| LLLLWFLPITEGSQR | 16 | Q9NQ79 | |
| SFWLLPPSLLLLLAS | 101 | P00395 | |
| LLIISWLPVLGFLQL | 366 | O00237 | |
| WQALPLILFAVLGLL | 491 | O15245 | |
| ALGFIISPWSLLLLP | 46 | Q12923 | |
| QHWLSLPLSLLFLLA | 31 | Q8NGH5 | |
| LSLLELLDFPPLFWV | 266 | Q96FM1 | |
| SAPLQVILALYLLWL | 446 | P33527 | |
| VILALYLLWLNLGPS | 451 | P33527 | |
| SGLLLLTWQKLAPIS | 126 | P03891 | |
| SPWKGSLLLLLVSNL | 6 | P01236 | |
| ILGPLLLWLLSYAIA | 91 | A0A087WTH1 | |
| AWGLLLVTYLLPLLV | 226 | P49683 | |
| LGVWILLLLASLTPL | 196 | Q96HP8 | |
| VLLLLGILAPLSSWD | 31 | A6NJY4 | |
| TLPLLFLGLSLLWTV | 291 | P0C7N4 | |
| FLGLSLLWTVLLDPG | 296 | P0C7N4 | |
| LTLPLLFLGLSLLWT | 291 | A6NGB0 | |
| LFLGLSLLWTVLLDP | 296 | A6NGB0 | |
| NWPTLILADLFDILL | 316 | O14827 | |
| LLLLNPWTAGLIVLV | 981 | Q9Y6C5 | |
| ISVPILLGWGLNLTL | 16 | Q8NGU9 | |
| INLGVWLASLLVTLP | 166 | P31391 | |
| LQSQSGWVPLLLALL | 116 | Q8TBK2 | |
| ALLLLQLLGWVFIPI | 86 | P53794 | |
| FWTPLLVVLLAGLGD | 6 | Q16586 | |
| LAADWLPSLLLLLEG | 171 | Q7RTU9 | |
| LPSLLLLLEGTRWQA | 176 | Q7RTU9 | |
| RPFIWALSLGILLSL | 86 | Q96JT2 | |
| DLPLSIWLLLKNPTF | 371 | Q96BD0 | |
| LLWLLPLLLSTAAVG | 6 | Q9UM73 | |
| PKFILSVLLLWNFGL | 141 | Q9BVK2 | |
| SEWLRLLPFLGVLAL | 36 | Q8N5K1 | |
| LLLSLLLLPTVGWQQ | 66 | Q9Y3P4 | |
| KVPELAGFWLLSLLL | 106 | Q86X19 | |
| AGFWLLSLLLQLPLI | 111 | Q86X19 | |
| FLLQWLIILDLSLFP | 56 | Q9NYW4 | |
| FLAWGEPAVLLLLLL | 561 | Q7RTX0 | |
| AFSSLGLLKVWLPLL | 616 | P07911 | |
| GLLKVWLPLLLSATL | 621 | P07911 | |
| GITLWPLLSRYLLEN | 151 | O15375 | |
| PLLWETQLGLAFLRG | 111 | O43557 | |
| TALILSPLLLLFALW | 546 | P04844 | |
| ILRPNLSLLWLSEQG | 176 | A6NE52 | |
| LWLLNALEGVPALLQ | 261 | Q6ZV50 | |
| PWTRLLLLLLVFAVG | 481 | Q6NUQ4 | |
| LPLLVSALVLGWLNL | 496 | Q9Y5S1 | |
| QLATGLLLLLSVQPW | 11 | P35504 | |
| EALTLLPISPLWSLL | 446 | P48067 | |
| LWLGVLPTLTLGLLV | 651 | O75326 | |
| LLLPLLSQPTLGSLW | 831 | Q9BWH6 | |
| LSLSDLLYALTLPLW | 56 | Q8IYL9 | |
| ELWFGLITSPLFILL | 111 | Q969S6 | |
| KTWLPFILLLGIILT | 186 | Q9H0R3 | |
| LAADWLPSLLLLLEG | 171 | A6NGW2 | |
| LPSLLLLLEGTRWQA | 176 | A6NGW2 | |
| LLLPNWDVTYLLRGL | 36 | Q96DZ7 | |
| RLATGLLLLLSVQPW | 11 | P22310 | |
| GLLLLWLPGVRFDIQ | 11 | A0A075B6H8 | |
| PKLATTALFLGLWLL | 891 | Q9UPR5 | |
| GQRILDPLLLLTWKT | 371 | Q8N1T3 | |
| GPEAWLLLLLLLASF | 11 | Q96NY8 |